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ABSTRACT 
The Effect of Ethanolic extracts of Centratherum anthelminticum on Diabetic rats Assessment of the antihyperglycemic effect of 
ethanolic extract of Centratherum anthelminticum seeds in normal and alloxan induced diabetic rats: The animals will be divided 
into nine groups and each group consisted of six rats. Group 1 as normal control. Group 2 as the diabetic control. Groups 3, 4 and 5 
are normally treated with 0.25 g, 0.50 g and 0.75 g/kg BW of CAEt, respectively. Groups 6, 7 and 8 are diabetic rats treated with 
0.25 g, 0.50 g, and 0.75 g/kg BW of CAEt, respectively. Group 9 are diabetic rats which received glibenclamide (0.02 g/kg BW) an 
oral hypoglycemic agent dissolved in distilled water. Normal control and the diabetic control rats are fed distilled water alone. After 
an overnight fast, the plant extract suspended in distilled water will feed to the rats by gastric intubation using a force feeding needle. 
Blood samples are collected for the measurement of blood glucose from the tail vein at 0, 1, 2, 3, 4, 5 and 6 h after the administration 
of plant extract and blood glucose levels are determined by Glucose oxidase – peroxidase method. The phytochemical analysis will 
be carried out in the ethanolic extract by different methods of phytochemical analysis. 
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INTRODUCTION 
Diabetes mellitus (DM) is a common metabolic disorder 
affecting people in both developed and developing 
countries. Diabetes can be divided into two main groups 
based on their requremantly for insulin. Insulin 
dependent diabetes mellitus (type 1) and non insulin 
dependent diabetes mellitus (type 2) the disease is 
characterized by chronic hyperglycemia, which is not 
effectively controlled can cause blindness, kidney failure 
or nerve damage. Type 2 diabetes is the most prevalent 
and accounts for approximately 90% of cases of diabetes 
mellitus worldwide and characterized by a combination 
of defects in insulin secretion and insulin sensitivity
7
. 
Glycaemic control is one of the targets for managing 
DM. studies have developing complications of diabetes
4
. 
The main side effects of insulin therapy and oral 
hypoglycemic agents necessitate a search for more 
effective and safer anti diabetic drugs
3
. Scientific search 
for hypoglycemic agents from medicinal plants as 
recommended by the world health organization (WHO 
expert committee 1980) has even more important in the 
last few decades. Over 500 herbal medicines have been 
reported to possess anti diabetic property
2
. Diabetes 
mellitus is one of the disease for which a satisfactory 
treatment is not available in modern allopathic system of 
medicine
6
. Therefore the search for an ideal drug for the 
treatment of diabetes containing and has been extended 
to herbs. Centratherum anthelminticum is an important 
drug of indigenous system of medicine and has been 
know for a number of medicinal properties in ayurveda
4
. 
Swarnkar et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2017; 7(4):73-77                                 
ISSN: 2250-1177                                                                              [74]                                                                            CODEN (USA): JDDTAO 
Centratherum anthelminticum is used as the folk 
medicine for diabetes in Rayalaseema of Andhra 
Pradesh of India. 
MATERIAL AND METHOD  
Plant materials collection 
The fresh seeds of Centratherum anthelminticum (Wild) 
Kuntze; Family Asteaceae were obtained from the 
commercial sources and identified and authntified by dr. 
Rakesh kumar Tewari  Professor & Head Department of 
Dravyaguna Bundelhand Government Ayurvedic 
College & Hospital Jhansi (U.P.) India sample was 
submitted in the museum (sample no.001A)   
 Drug and chemical 
Preparation of extract   
All the chemicals were analytical grade. Standard kit of 
RIA serum insulin level, GOD,-POD kit serum glucose 
level, other biochemical kits were obtained from was 
obtained from anmol pharma Jaipur (Rajasthan) 
The dried seed were grinded and 500 gm of seed powder 
was soaked in ethanol (2L; 95%) for overnight at room 
temperature. Then filtered through Whatmann paper 
No.42 (125mm) filter paper twice and concentrated at 
40
0
C till dryness in a rotary vacuum evaporator. Finally 
obtained brown residue termed as ethanolic seed (extract 
CTEt) that was stored in refrigerator below 10
0
until 
used
5
     
Experimental animals 
Healthy Swiss albino rats weighing about (180-250gm) 
of either sex were obtained from animal house, institute 
of pharmacy, Bundelkhand university jhansi. The 
animals were housed in specific standard laboratory 
conditions. The conditions were kept in a tempretaure-
controlled environment(25+1
0
c) and with a regular 12h 
light/12hr dark cycle. All animals were fed with 
commercial diet and water during experiment. All 
protocols of the study were approved by instititional 
animal ethical committee with reference number 
BU/PHARM/IAEC/12/O42. The IAEC is approved by 
committee for the purpose of control and supervision of 
experiments of animals (CPCSEA) with registration 
number 716/02/a/CPCSEA. 
Experiment and Group of Rats  
The animals will be divided in to nine groups and each 
group consisted of six rats.  Group 1 as normal control.  
Group 2 as the diabetic control. Groups 3, 4 and 5 are 
normal treated with 0.25 g, 0.50 g and 0.75 g/kg bw of 
CAEt, respectively. Groups 6, 7 and 8 are diabetic rats 
treated with 0.25 g, 0.50 g and 0.75 g/kg bw of CAEt, 
respectively. Group 9 are diabetic rats which received 
glibenclamide (0.02 g/kg bw) an oral hypoglycemic 
agent dissolved in distilled water. Normal control and 
the diabetic control rats are fed distilled water alone. 
After an overnight fast, the plant extract suspended in 
distilled water will fed to the rats by gastric intubation 
using a force feeding needle. Blood samples are 
collected for the measurement of blood glucose from the 
tail vein at 0, 1, 2, 3, 4, 5 and 6 h after the administration 
of plant extract and blood glucose levels are determined 
by Glucose oxidase – peroxidase method. 
Phytochemical analysis will carried out in the ethanolic 
extract by different methods of phytochemical analysis. 
Induction of Diabetes  
In humans, diabetes mellitus is one of the most prevalent 
conditions with spontaneous manifestation. In animals, it 
can be induced by partial pancreatectomy or by the 
administration of diabetogenic drugs such as alloxan, 
streptozotocin, ditizona and anti-insulin serum. These 
agents selectively destroy the Langerhans islet ß-cells. 
The best known drug-induced diabetes model is the 
alloxan diabetes. Alloxan, a derivative of uric acid, as 
well as of other substances of different chemical groups, 
cases ß-cells to degranulate and consequently 
degenerate. Alloxan induces irreversible diabetes 
mellitus after 24 hours following its administration and 
the condition proves to be chronic by laboratory tests 
after seven days. After a 48- hour fast, the rats are 
weighed and anesthetized by inhalation in a glass dome. 
A solution of alloxan at 2% diluted in saline at 0.9% will 
administered to the animals in a single dose 
corresponding to 40 mg of alloxan per kg of animal 
weight injected in to their penial vein
1
. 
Evaluation of Biochemical Parameters 
Estimation of serum glucose level (GOD-POD method), 
serum insulin level (RIA method), serum cholesterol 
(enzymatic method), HDL cholesterol (enzymatic 
method), serum triglyceride (enzymatic method), serum 
urea (berthelot method) and creatinine (alkaline picrate 
method) will be estimate. VLDL-cholesterol and LDL- 
cholesterol are calculated as per Friedewald' equation. 
VLDL-cholesterol = total serum triglycerides/5 
LDL-cholesterol= Total serum cholesterol- total serum 
triglycerides/5-HDL-C 
Statistical Analysis 
Results were presented as mean SEM. Statistical 
differences between the means of the various groups 
were evaluated using one-way analysis of variance 
followed by turkey’s multiple parametric tests. Data 
were considered statistically significant at P value ≤ 0.05 
and highly significant at P 0.001. Statistical analysis was 
performed using Sigma stat statistical software 
(Ver.2.03).
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RESULTS   
Table 1: Effect of ethanolic extract CAEt  treatment on general features of diabetic rats. 
Parameter Group1 
n=6 
Group2 
n=6 
Group3 
V 
Group4 
n=6 
Group5 
n=6 
Group6 
n=6 
Group7 
n=6 
Group8 
n=6 
Group9 
n=6 
Average Body 
weight(gm/day) 
230.30
 
±0.50 
211.32
** 
±2.50 
219.50 
±2.10 
195.20 
±1.30 
185.50 
±2.25 
215.25 
±1.25 
220.20
* 
±1.50 
212.12 
±1.20 
230.10
** 
±1.70 
Food 
intake(gm/animal/day 
20.77 
±0.53 
42.81
** 
±0.82 
22.19 
±0.55 
21.30 
±0.42 
20.20 
±0.58 
22.50 
±0.50 
22.60 
±0.53 
21.10
* 
±0.48 
19.90
** 
±0.51 
Water 
intake(ml/animal/day 
22.21 
±0.42 
72.22
** 
±1.11 
21.22
* 
±0.52 
22.00 
±0.63 
28.12 
±0.59 
62.54 
±0.42 
62.12 
±0.63 
61.59
* 
±0.52 
58.56
** 
±2.22 
Values are expressed as Mean ±SEM 
** Significantly different control (p˂0.001) 
* Significantly different from diabetic control (p˂0.05) 
** Significantly different from diabetic control (p˂0.001) 
 
 
Figure 1: Effect of ethanolic extract CAEt of treatment on general features of diabetic rats 
 
Table 2: Effect of different doses of ethanolic extract of Centratherum anthelminticum on fasting Blood glucose level 
(mg/dl) of normal and diabetic rats (Mean±SEM) 
Treatment                                              Time(Hrs)                  
0Hrs 1Hrs 2Hrs 3Hrs 4Hrs 5Hrs 6Hrs 
Group1 
n=6 
79.59±2.11 78.15±2.20 81.31±1.56 82.10±2.21 81.51±1.19 78.61±2.31 77.43±1.56 
Group2 
n=6 
272.52±5.52 278.32±7.35 276.59±6.31 277.51±6.32 272.33±7.32 271.51±7.71 272.39±7.21 
Group3 
n=6 
81.12±1.82 79.74±1.64 
1.7% 
77.91±1.81 
4.0% 
75.12±2.12 
7.4% 
70.19±2.31** 
13.5% 
67.52±0.91*** 
16.8% 
74.60±1.42* 
8.0% 
Group4 
n=6 
79.23±1.32 
 
71.82±2.11 
9.4% 
70.12±1.51 
11.5% 
69.21±1.39 
12.6% 
68.01±1.92*** 
14.2% 
66.91±1.11*** 
15.5% 
68.21±2.01*** 
13.9% 
Group5 
n=6 
77.71±1.91 71.01±2.11 
8.6% 
70.03±1.21 
9.9% 
68.11±2.22 
12.4% 
59.22±1.17*** 
23.8% 
54.47±1.01*** 
29.9% 
61.99±1.70** 
.20.2% 
Group6 
n=6 
268.52±4.69 260.32±5.12 
3.0% 
258.17±3.12 
3.9% 
252.72±3.33 
5.9% 
247.54±4.41** 
7.8% 
231.32±2.22*** 
13.6% 
246.12±2.32** 
8.3% 
Group7 
n=6 
272.15±2.12 251.31±2.23 
7.7% 
236.50±4.21 
13.0% 
212.32±3.31* 
22% 
196.92±3.32*** 
27% 
185.21±3.12*** 
32% 
180.42±4.42*** 
33.7% 
Group8 
n=6 
352.40±8.21 342.52±7.71 
2.8% 
302.82±8.12 
14.0% 
270.62±3.17 
23.2% 
245.32±6.65*** 
30.4% 
225.72±8.80*** 
35.9% 
212.35±6.20*** 
39.7% 
Group9 
n=6 
268.31±11.8
0 
252.34±8.91 
6.0% 
248.21±9.61 
13.3% 
232.19±8.76 
18.9% 
229.71±11.90* 
19.8% 
176.21±6.63*** 
38.5% 
210.30±9.16** 
26.5% 
Values in Parenthesis are percentage of decreases in Blood glucose- 
*P˂0.05 compared with the initial level of blood glucose (0h) in the respective group 
**P˂0.01 compared with the initial level of blood glucose (0h) in the respective group 
***P˂0.001 compared with the initial level of blood glucose (0h) in the respective group 
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Figure 2: Effect of different doses of ethanolic extract of Centratherum anthelminticum on fasting Blood glucose level (mg/dl) of 
normal and diabetic rats 
Table 3: Effect of ethanolic extract C.A of treatment on biochemical parameters of diabetic rats 
PARAMETER Group1  
n=6 
Group2 
n=6 
Group3 
n=6 
Group4 
n=6 
Group5 
n=6 
Group6 
n=6 
Group7 
n=6 
Group8 
n=6 
Group9 
n=6 
Total 
cholesterol(mg/dl) 
79.20 
±6.26 
104.52
* 
±1.4 
81.37 
±4.23 
82.44 
±3.31 
84.37 
±5.24 
87.55
* 
±4.41 
90.41
* 
±4.44 
91.37 
±4.53 
87.90
* 
±5.55 
HDL 
cholesterol(mg/dl) 
45.08 
±2.48 
25.67
** 
±2.4 
40.05 
±3.32 
41.07 
±4.79 
42.06 
±3.78 
30.39 
±2.20 
31.72 
±3.20 
31.62 
±1.41 
36.01
* 
±2.68 
LDL 
cholesterol(mg/dl) 
19.35 
±6.21 
54.33
** 
±1.32 
21.32 
±5.51 
22.47 
±4.42 
24.33 
±3.41 
41.23 
±3.30 
42.37 
±2.21 
40.61
* 
±4.16 
32.82
** 
±4.04 
VLDL 
cholesterol(mg/dl) 
17.14 
±1.21 
26.54
** 
±1.34 
19.27 
±1.37 
22.42 
±3.48 
21.72 
±3.17 
22.22 
±2.36 
21.47 
±3.12 
21.26
* 
±0.52 
20.06
* 
±0.72 
Serum 
Triglyceride(mg/dl) 
82.75 
±3.01 
126.51
** 
±6.67 
84.57 
±2.27 
84.58 
±2.74 
85.79 
±2.23 
106.40 
±2.29 
105.46 
±3.37 
104.31 
±3.21 
96.48
* 
±4.50 
Serum 
Creatinine(mg/dl)   
1.06 
±0.07 
1.35
* 
±0.03 
1.05 
±0.06 
1.05 
±0.04 
1.07 
±0.05 
1.03
* 
±0.03 
1.31 
±0.07 
1.28 
±0.02 
1.12
* 
±0.08 
Serum  
Urea (mg/dl) 
45.91 
±0.77 
91.31
** 
±6.07 
46.92 
±0.79 
48.28 
±1.12 
50.47 
±2.31 
70.23 
±1.20 
72.48 
±2.76 
68.45
* 
±2.58 
67.73
* 
±7.60 
Values are expressed as Mean ±SEM 
* Significantly different from normal control (p˂0.05) 
** Significantly different from normal control (p˂0.001) 
* Significantly different from diabetic control (p˂0.05) 
** Significantly different from diabetic control (p˂0.001) 
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DISCUSSION AND CONCLUSION 
Intravenous injection of Alloxan in a single dose 
corresponding to 40 mg of alloxan per kg of animal 
weight injected into their penial vein produced cardinal 
signs of type1 diabetes i.e. loss of body weight, 
polyphagia, and polydipsia.(Table-1) chronic treatment 
with ethanolic extract of CA(0.75g /kg / p.o./20days) 
was found to prevent the loss of body weight 
(212.12±1.20 gm /animal/day group8
th 
Vs 211.32±2.50 
gm /animal/day group2
nd
 ) and significantly decreases 
the food intake  (21.10±0.48 gm /animal/day group8
th 
Vs 
42.81±0.82 gm /animal/day group2
nd
 ) and water intake 
(61.59±0.52 ml /animal/day group8
th 
Vs 72.22±1.11ml 
/animal/day group2
nd
 ) as compare to group 2
nd
. Group 
3,4,5, compare with group1slightly change in body 
weight, food intake and water intake. 
The effect of different doses of the ethanolic extract of 
Centratherum anthelminticum kuntz on fasting glucose 
of alloxan induced diabetic rats is shown in (table-2) the 
ethanolic extract significantly (p ˂ 0.05) lowered fasting 
blood glucose of both normal and diabetic rats.0.75g/kg 
dose of ethanolic extract of Centratherum 
anthelminticum kuntz produced the maximal fall of 
29.9%in normal rats and 39.7% in diabetic rats.  
Diabetic rats (group 2
nd
) were found to have 
significantly increases serum cholesterol. LDL-
cholesterol, VLDL- cholesterol, and triglycerides level 
as compared to group 1.HDL- cholesterol was also 
reduced significantly in diabetic rats. Treatment of 
ethanolic extract of CA in different doses or 
glibenclamide significantly preventing the increase in 
serum cholesterol LDL- cholesterol and VLDL- 
cholesterol serum triglycerides levels as compared to 
group decreased non significantly in group2
nd
.treatment 
with the ethanolic extract of different doses of CA or  
glibenclamide produced significant increase in HDL- 
cholesterol level as compared to in group 2
nd
. Insulin 
diabetic rats exhibited significantly higher serum urea 
level and serum creatinine level as compared to those of 
group 1.chronic treatment with ethanolic extract of 
Centratherum anthelminticum and glibenclamide 
significantly prevented this increase in serum urea and 
serum creatinine level of group 2
nd 
(Table-3). 
From these results, we conclude that ethanolic extract of 
Centratherum anthelminticum decreased glucose levels, 
increased insulin level
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